CHU Saint-Etienne
Saint-Etienne, France
NCT Number: NCT06255301
In order to develop innovative biomarkers for the diagnosis of two ocular surface pathologies, Dry Syndrome (DS) and Limbic Stem Cell Deficiency (LSCD), human cells from the ocular surface will be collected in order to test these biomarkers ex vivo.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Saint-Etienne, France
To collect them, cytological fingerprints of the ocular surface are made using filter paper applied to the surface using a commercially available EC (European Conformity)-marked medical device, called EYEPRIM.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Collection of conjunctival impressions using the EC(European Conformity )-marked EYEPRIM device . This device enables cells to be collected the superficial ocular surface cells by applying a membrane for few seconds to the ocular surface.
Time frame: day one
Collection of cells from the ocular surface by performing a cytological imprint of the ocular surface
Centre Hospitalier Universitaire de Saint Etienne
Other
Acronym: ESSO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06455826
Eye Diseases, Eye Diseases, Hereditary
Jacksonville, Florida, United States
View Trial DetailsNCT02710916
Eye Diseases, Glaucoma
Bordeaux, Aquitaine, France
View Trial DetailsNCT05656027
Eye Diseases, Myopia
Chandler, Arizona, United States
View Trial DetailsNCT05753189
Eye Diseases, Myopia
Dothan, Alabama, United States
View Trial Details